Caprolactam Chemicals Ltd (CAPRO) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Caprolactam Chemicals Ltd on NSE and BSE, with an AI summary of each filing.
Caprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Prior Intimation of board ....
Intimation · 13 Nov 2026, 5:30 am
Caprolactam Chemicals Schedules Board Meeting for Unaudited Financial Results Caprolactam Chemicals Ltd. has scheduled a meeting of its Board of Directors on 13th Nov'26 to consider, approve, and record the company's unaudited financial results for the half year ended 30th Sep'26. Additionally, the trading window for dealing in company securities has been closed effective 1st Oct'26 and will remain shut until 48 hours following the public announcement of the financial results, in compliance with SEBI insider trading regulations.
Non-applicability of Regulation 27(2) of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 13 Oct 2026, 12:04 am
Caprolactam Chemicals Claims Exemption from SEBI LODR Corporate Governance Reporting Caprolactam Chemicals Limited claimed an exemption under Regulation 15(2)(a) of SEBI LODR Regulations from submitting the Corporate Governance Report for the quarter ended 30th Sep'26. As of 31st Mar'26, the company’s paid-up equity share capital stood at Rs 4.60 crore (below the Rs 10 crore threshold) and net worth stood at Rs 6.58 crore (below the Rs 25 crore threshold). Certified data showed paid-up capital remained at Rs 4.60 crore across FY24–FY26, while net worth was Rs 5.54 crore as of 31st Mar'24 and Rs 4.82 crore as of 31st Mar'25.
Disclosure under regulation 30 (LODR) regulations, 2015
Change in Auditor · 30 Sept 2026, 11:39 pm
Consolidated Report of the Scrutinizer
Annual General Meeting · 29 Sept 2026, 11:58 pm
Caprolactam Chemicals Shareholders Approve All Resolutions at 37th AGM Caprolactam Chemicals Limited announced that shareholders approved all three ordinary resolutions with 100% majority at its 37th AGM held on 28th Sep'26. A total of 52 members representing 2,649,789 votes cast their ballots entirely via remote e-voting with zero dissenting or invalid votes. Approved items include the adoption of audited financial statements for FY26, the reappointment of Mrs. Zaver Shankarlal Bhanushali as Director, and the appointment of Raman S. Shah & Co. as statutory auditors for a five-year term ending at the 42nd AGM in FY31.
Outcome of AGM
Annual General Meeting · 29 Sept 2026, 1:51 am
Announcement under Reg 30(LODR) Resignation and Appointment of the Internal Auditor of the Company
Change in Auditor · 10 Sept 2026, 9:24 pm
Caprolactam Chemicals Announces Change in Internal Auditor Caprolactam Chemicals Limited has announced that M/s. Shrey Pandey & Associates resigned as Internal Auditor, effective 10th Sep'26, citing pre-occupation with other professional commitments and raising no management concerns. Concurrently, the Board approved the appointment of M/s. Parth Patel D & Associates as the new Internal Auditor with immediate effect on 10th Sep'26 for FY27. The newly appointed firm has no relationships with any directors of the company.
Annual Report for FY 2025-26
Others (Uncategorized) · 02 Sept 2026, 9:43 pm
Notice of Annual General Meeting on 28th September, 2026
Annual General Meeting · 02 Sept 2026, 9:23 pm
Recommendation for Appointment of Statutory Auditor and Others Agenda items
Others (Uncategorized) · 31 Aug 2026, 11:01 pm
Caprolactam Chemicals Board Recommends New Statutory Auditor The Board of Caprolactam Chemicals Ltd., on 31 Aug'26, recommended appointing M/s. Raman S. Shah & Co as Statutory Auditors. The appointment is subject to shareholder approval at the upcoming 37th AGM, scheduled for 28 Sep'26. The proposed term will run until the conclusion of the 42nd AGM. Additionally, the Board set the record date for AGM e-voting as 21 Sep'26, with the e-voting period from 24 Sep'26 to 27 Sep'26. Proposed audit fees are ₹1,100,000 plus taxes.
Outcome of Board Meeting
Outcome · 13 Aug 2026, 6:57 pm
Caprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Prior Intimation of board ....
Intimation · 13 Aug 2026, 5:30 am
Caprolactam Chemicals Board to Approve Q1 FY27 Results on 13 Aug'26 Caprolactam Chemicals (BSE: 507486) announced its Board of Directors will meet on 13 Aug'26 to consider and approve the unaudited financial results for the quarter ended 30 Jun'26. In accordance with SEBI regulations, the trading window for dealing in the company's securities has been closed from 01 Jul'26. The window will reopen 48 hours after the financial results are publicly announced. This meeting is a key event for tracking the company's Q1 FY27 performance.
Outcome of the Board Meeting held on Saturday, 30 May, 2026
Outcome · 30 May 2026, 10:57 pm
Caprolactam Chemicals Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakh) ■ Revenue: 307 (+90.7% YoY | +19.7% QoQ) ■ EBITDA: 165 (+628.2% YoY | +49.4% QoQ) ■ EBITDA Margin (%): 53.9 (+3980 bps YoY | +1073 bps QoQ) ■ PAT: 83.8 (Loss to Profit YoY | +92.3% QoQ) ■ EPS (INR): 1.82 (Loss to Profit YoY | +91.6% QoQ)
Caprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Prior Intimation of Board ....
Intimation · 30 May 2026, 5:30 am
Caprolactam Chemicals Board to Approve FY26 Results on May 30 Caprolactam Chemicals Ltd. (BSE: 507486) has scheduled a Board of Directors meeting on 30th May'26 to consider and approve the audited financial results for the quarter and financial year ended 31st Mar'26. The company also announced that its trading window for dealing in securities has been closed from 1st Apr'26 and will reopen 48 hours after the results are made public. This action is in accordance with SEBI's insider trading regulations.
Non Applicability of Regulation 23(9) of SEBI (LODR) Regulations, 2015
Others (Uncategorized) · 22 Apr 2026, 6:03 pm
Caprolactam Chemicals Exempt from Related Party Transaction Disclosures Caprolactam Chemicals Ltd. informed exchanges on 22-Apr'26 that Regulation 23(9) of SEBI (LODR) Regulations, regarding Related Party Transaction disclosures, is not applicable to the company. This exemption is due to its paid-up equity share capital of Rs. 4.60 crore and net worth of Rs. 4.96 crore as of 31-Mar'25, which are below the SEBI-prescribed thresholds of Rs. 10 crore and Rs. 25 crore, respectively. Consequently, the company is not required to submit these disclosures.
<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> ....
Others (Uncategorized) · 18 Apr 2026, 11:23 pm
Caprolactam Chemicals Confirms It Is Not a Large Corporate Caprolactam Chemicals Ltd. informed the BSE on 18-Apr'26 that it does not fall under the 'Large Corporate' category as defined by SEBI's circular on mandatory debt issuance. The company's outstanding borrowings were reported as Rs 9.23 crore as of 31-Mar, which is below the threshold for the framework. Consequently, the company is not required to raise a portion of its incremental borrowings via debt securities.
Intimation of calendar of events for Postal Ballot
Others (Uncategorized) · 25 Feb 2026, 8:37 pm
Caprolactam Chemicals to Seek Shareholder Approval for Key Resolutions via Postal Ballot Caprolactam Chemicals will conduct a postal ballot to seek shareholder approval for four resolutions decided on 13th Feb'26. These include special resolutions for revising the remuneration of the CFO, Siddharth Bhanushali, and the MD, Zaver Bhanushali. Ordinary resolutions cover a property leasing transaction with related party Shital Bhanushali and a revision in consultancy fees for Shankar Bhanushali. The e-voting period is scheduled from 28th Feb'26 to 29th Mar'26, with the results to be declared on 30th Mar'26.
Result For Quarter ended Dec 2025
Financial Result · 13 Feb 2026, 10:28 pm
Caprolactam Chemicals Ltd. - Financial Result for the Quarter ended 31st Dec'25 (Standalone, INR Lakhs) ■ Revenue: 256 (+11.7% YoY | +8.5% QoQ) ■ EBITDA: 111 (+134.2% YoY | +67.9% QoQ) ■ EBITDA Margin (%): 43.2 (+2258 bps YoY | +1529 bps QoQ) ■ PAT: 43.6 (Loss to Profit YoY | +246.7% QoQ) ■ EPS (INR): 0.95 (Loss to Profit YoY | +251.9% QoQ)
Caprolactam Chemicals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2026 ,inter alia, to consider and approve Unaudited financial results ....
Intimation · 13 Feb 2026, 5:30 am
Caprolactam Chemicals Board Meeting on 13 Feb'26 for Q3 Results, Dividend Caprolactam Chemicals (BSE: 507486) will hold a Board of Directors meeting on 13 Feb'26 to consider and approve unaudited financial results for the quarter ended 31 Dec'25. The board will also consider a recommendation for an equity dividend payment. The trading window for designated persons has been closed from 01 Jan'26 and will reopen 48 hours after the financial results are declared.
Submission of Disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 Form C
Others (Uncategorized) · 01 Dec 2025, 11:16 pm
Caprolactam Chemicals Promoter Shital S. Bhanushali Increases Stake Shital S. Bhanushali, a promoter of Caprolactam Chemicals Ltd., increased her holding in the company through a series of open market purchases on the BSE between 20 Nov'25 and 01 Dec'25. The transactions involved the acquisition of 20,585 equity shares in total. Following these purchases, her stake in the company increased from 339,437 shares (7.38%) to 360,022 shares (7.83%). The company formally disclosed this change in promoter shareholding to the exchange on 01 Dec'25.
Submission of Disclosure under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 Form C
Others (Uncategorized) · 01 Dec 2025, 11:15 pm
Caprolactam Chemicals Promoter Shital S. Bhanushali Increases Shareholding Shital S. Bhanushali, a promoter of Caprolactam Chemicals Ltd., increased her stake in the company through a series of open market purchases between 20th Nov'25 and 1st Dec'25. The transactions involved the acquisition of 20,585 equity shares in total. Following these purchases, her shareholding increased from 339,437 shares (7.38%) to 360,022 shares, representing 7.83% of the company's equity. The company disclosed these transactions to the BSE on 1st Dec'25.
Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Others (Uncategorized) · 01 Dec 2025, 10:27 pm
Promoter Shital S. Bhanushali Increases Stake in Caprolactam Chemicals Promoter Shital S. Bhanushali acquired 5,420 shares of Caprolactam Chemicals Limited through an open market transaction on 28th Nov'25. This acquisition increased her individual shareholding from 354,602 shares (7.71% of total capital) to 360,022 shares (7.83%). Following this transaction, the total promoter and Persons Acting in Concert (PAC) group holding in the company rose from 54.37% to 54.49%.
Disclosures under Regulations 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Others (Uncategorized) · 28 Nov 2025, 10:05 pm
Promoter Shital S. Bhanushali Increases Stake in Caprolactam Chemicals Promoter Shital S. Bhanushali acquired 3,521 shares of Caprolactam Chemicals Limited through an open market transaction on 27th Nov'25. This purchase increased her individual shareholding from 351,081 shares (7.63%) to 354,602 shares, representing 7.71% of the company's total issued share capital. Following this acquisition, the total holding of the promoter and persons acting in concert (PAC) increased from 54.29% to 54.37% of the total voting capital.
Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Others (Uncategorized) · 28 Nov 2025, 9:56 pm
Promoter Shital S. Bhanushali Increases Stake in Caprolactam Chemicals Promoter Shital S. Bhanushali acquired 1,054 shares of Caprolactam Chemicals Limited through an open market transaction on 26th Nov'25. This purchase increased her individual shareholding from 350,027 shares (7.61%) to 351,081 shares, representing 7.63% of the company's total voting capital. Following this acquisition, the total holding of the promoter and Persons Acting in Concert (PAC) increased from 54.27% to 54.29%. The disclosure was made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Others (Uncategorized) · 26 Nov 2025, 11:10 pm
Disclosures under Regulation 29 (2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
Others (Uncategorized) · 25 Nov 2025, 4:14 pm